Biotech | July 07, 2025
Godavari Biorefineries' anti-cancer patent now validated in Spain and UK
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
ARGX-119 is the sixth molecule developed through our Immunology Innovation Program to show proof-of-concept
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
Subscribe To Our Newsletter & Stay Updated
